Evidence map›Paper›PMID 41251706›Full record

Observational studyActa diabetologica2026

Characteristics of above 65-year-olds with type 1 diabetes in the Finnish diabetic nephropathy study.

Emilia M C Franzén, Marika I Eriksson, Susanna Satuli-Autere, Anni Ylinen, Fanny Jansson Sigfrids, Jenna Nicklén, Hanna Öhman, Per-Henrik Groop, Lena M Thorn, FinnDiane Study Group

Abstract readObservational Study
In one paragraph

Observational study in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emilia M C FranzénFolkhälsan Research Center, Helsinki, Finland.
Marika I ErikssonFolkhälsan Research Center, Helsinki, Finland.
Susanna Satuli-AutereFolkhälsan Research Center, Helsinki, Finland.
Anni YlinenFolkhälsan Research Center, Helsinki, Finland.
Fanny Jansson SigfridsFolkhälsan Research Center, Helsinki, Finland.
Jenna NicklénFolkhälsan Research Center, Helsinki, Finland.
Hanna ÖhmanDepartment of Geriatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Per-Henrik GroopFolkhälsan Research Center, Helsinki, Finland.
Lena M ThornFolkhälsan Research Center, Helsinki, Finland. lena.thorn@helsinki.fi.ORCID http://orcid.org/0000-0003-3999-0390
FinnDiane Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAgeing in people with type 1 diabetes is identified as a research gap. Therefore, the aim of our study is to characterize above 65-year-olds with type 1 diabetes, and to identify potential protective factors or factors related to increased risk of mortality in this age group.

methodsThis observational study includes 864 participants aged 55 years or older with type 1 diabetes (age at onset below 40) from the Finnish Diabetic Nephropathy Study, grouped according to age into three categories: 55-60, 60-65, and > 65 years old. Multivariable logistic regression analysis was used to identify factors independently associated with age above 65. Cox regression analysis was conducted to assess how these factors impact survival.

resultsFactors that were independently associated with age above 65 years included: higher diabetes onset age, higher pulse pressure, lower mean arterial pressure, absence of current smoking and diabetic kidney disease, history of severe diabetic retinopathy and cardiovascular events, lower daily insulin dose, lower HbA

conclusionAbove 65-year-olds were characterized by both factors generally related to positive and negative health outcomes. Additionally, different factors were found to be associated with reaching older age and with survival beyond the age of 65.

Indexed as

Diabetes Mellitus, Type 1Diabetic NephropathiesAgedAge FactorsFemaleFinlandGlycated HemoglobinHumansMaleMiddle AgedRisk FactorsGlycated HemoglobinAgeingCardiometabolic risk factorsDiabetes complicationsDiabetes mellitus, type 1

Identifiers

PMID41251706
PMCPMC12956997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.